Anastasios Stathis

Anastasios Stathis

UNVERIFIED PROFILE

Are you Anastasios Stathis?   Register this Author

Register author
Anastasios Stathis

Anastasios Stathis

Publications by authors named "Anastasios Stathis"

Are you Anastasios Stathis?   Register this Author

59Publications

1863Reads

50Profile Views

In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas.

Br J Haematol 2019 Jul 19;186(1):149-152. Epub 2018 Dec 19.

Institute of Oncology Research (IOR), Università della Svizzera italiana (USI), Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15727DOI Listing
July 2019

Bromodomain and Extra-Terminal domain inhibitors for lymphoid malignancies.

Curr Opin Hematol 2019 Jul;26(4):273-280

Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000519DOI Listing
July 2019

Use of epirubicin to treat diffuse large B-cell lymphoma.

Lancet Haematol 2019 06;6(6):e292-e293

Ospedale San Giovanni, Bellinzona 6500, Switzerland; Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Department of Medical Oncology, Inselspital-Bern University Hospital, Bern, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30082-1DOI Listing
June 2019

Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma.

Br J Haematol 2019 Mar 2;184(6):1022-1025. Epub 2018 Apr 2.

IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15212DOI Listing
March 2019

Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: A meta-analysis.

Eur J Clin Invest 2019 Mar 11;49(3):e13063. Epub 2019 Jan 11.

Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/eci.13063DOI Listing
March 2019

BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer.

Curr Oncol Rep 2019 Feb 4;21(2):13. Epub 2019 Feb 4.

Medical Oncology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, 6500, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0762-xDOI Listing
February 2019

Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors.

J Clin Oncol 2018 10 7;36(30):3007-3014. Epub 2018 May 7.

Jeremy Lewin and Lillian L. Siu, Princess Margaret Cancer Center, Toronto, Ontario, Canada; Jean-Charles Soria and Christophe Massard, Institut Gustave Roussy and University Paris-Sud, Villejuif; Jean-Pierre Delord, Institut Claudius Regaud Oncopole, Toulouse; Mohamed Bekradda, Oncology Therapeutic Development, Clichy; Keyvan Rezai, Hôpital René Huguenin, Saint-Cloud, France; Anastasios Stathis, Oncology Institute of Southern Switzerland, Bellinzona; Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Ahmad Awada and Philippe G. Aftimos, Université Libre de Bruxelles, Brussels, Belgium; and Zhen Zeng, Azher Hussain, and Susan Perez, Merck & Co, Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.2292DOI Listing
October 2018

Reporting of immune checkpoint inhibitor-associated myocarditis.

Lancet 2018 08;392(10145):383-384

Institute of Pharmacological Sciences of Southern Switzerland, Division of Clinical Pharmacology and Toxicology, Ente Ospedaliero Cantonale, Lugano, 6903 Switzerland; University Hospital Zurich, Department of Clinical Pharmacology and Toxicology, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)31557-5DOI Listing
August 2018

BET Proteins as Targets for Anticancer Treatment.

Cancer Discov 2018 01 20;8(1):24-36. Epub 2017 Dec 20.

Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-17-0605DOI Listing
January 2018

Uncommon somatic mutations in metastatic NUT midline carcinoma.

Tumori 2017 Nov 15;103(Suppl. 1):e5-e8. Epub 2017 Nov 15.

Medical Oncology Department, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000685DOI Listing
November 2017

Cancer-specific geriatric assessment and quality of life: important factors in caring for older patients with aggressive B-cell lymphoma.

Support Care Cancer 2017 09 13;25(9):2833-2842. Epub 2017 Apr 13.

Institute of Social and Preventive Medicine (ISPM), University of Bern, Finkenhubelweg, 11 3012, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-017-3698-4
Publisher Site
http://dx.doi.org/10.1007/s00520-017-3698-4DOI Listing
September 2017

Staining the target: CD37 expression in lymphomas.

Blood 2016 12;128(26):3022-3023

ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-11-748137DOI Listing
December 2016

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).

Oncologist 2015 Oct 12;20(10):1149-53. Epub 2015 Aug 12.

Divisions of Hematology and Hematopathology, Mayo Clinic, Rochester, Minnesota USA; Hospital of Bolzano, Department of Hematology & Center of Bone Marrow Transplantation, Bolzano, Italy; Department of Hematology and Oncology, University Hospital Innsbruck, Innsbruck, Austria; University Hospital of Crete, Heraklion, Greece; Athens Medical Center-Psychikon Branch, Athens, Greece; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Hematology Unit, Department of Internal Medicine, Ospedale degli Infermi, Biella, Italy; Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; Hospital Clínic, Hematology, Barcelona, Spain; Cancer Research UK Centre, Southampton, United Kingdom; Dipartimento Biotecnologie Cellulari ed Ematologia, Universitá La Sapienza, Rome, Italy; European Institute of Oncology, Division of Clinical Haemato-Oncology, Milan, Italy; APHP, Saint-Louis Hospital, Hemato-Oncology, and Diderot University-Sorbonne Paris Cité, Paris, France; Département de Pathologie, Groupe Henri Mondor-Albert Chenevier, AP-HP, Creteil, France; Diagnostic Haematopathology, European Institute of Oncology, Milan, Bologna University School of Medicine, Bologna, Italy; St. James's University Hospital, Leeds, United Kingdom; Hospital Clinic, Anatomia Patologica, IDIBAPS, Barcelona, Spain; ICP Locarno, Locarno, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0180DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591947PMC
October 2015

A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis.

Tumori 2015 Jun 25;101(3):e99-e102. Epub 2015 Jun 25.

1 Lymphoma Unit, Oncology Institute of Southern Switzerland, Bellinzona - Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000283DOI Listing
June 2015

Management of the marginal zone lymphomas.

Cancer Treat Res 2015 ;165:227-49

Lymphoma Unit, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, 6500, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-13150-4_9DOI Listing
April 2015

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.

Br J Haematol 2014 Jul 27;166(1):69-76. Epub 2014 Mar 27.

Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, AOU Maggiore della Carità, Novara, Italy; Haematology Unit, Department of Internal Medicine, Ospedale degli Infermi, Biella, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12845DOI Listing
July 2014

An Unusual Case of Plasmablastic Lymphoma Presenting as Paravertebral Mass Evaluated by (18) F-FDG PET/CT.

Nucl Med Mol Imaging 2014 Mar 22;48(1):89-90. Epub 2013 Nov 22.

Department of Nuclear Medicine and PET/CT Centre, Oncology Institute of Southern Switzerland, Via Ospedale, 12, 6500 Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13139-013-0251-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035158PMC
March 2014

The management of nongastric MALT lymphomas.

Oncology (Williston Park) 2014 Jan;28(1):86-93

View Article

Download full-text PDF

Source
January 2014

Risk factors of central nervous system relapse in mantle cell lymphoma.

Leuk Lymphoma 2013 Sep 20;54(9):1908-14. Epub 2013 Feb 20.

Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont and Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.767454DOI Listing
September 2013

Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells.

Cancer Sci 2012 Aug 26;103(8):1397-404. Epub 2012 Jun 26.

Institute of Oncology Research, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2012.02321.xDOI Listing
August 2012

MALT lymphomas: pathogenesis can drive treatment.

Oncology (Williston Park) 2011 Nov;25(12):1134-42, 1147

Lymphoma Unit and Institute of Oncology Research, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
November 2011

Treatment of gastric marginal zone lymphoma of MALT type.

Expert Opin Pharmacother 2010 Sep;11(13):2141-52

Oncology Institute of Southern Switzerland - IOSI, Ospedale San Giovanni, CH-6500 Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2010.497141DOI Listing
September 2010

Targeting Wee1-like protein kinase to treat cancer.

Drug News Perspect 2010 Sep;23(7):425-9

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1358/dnp.2010.23.7.1490760DOI Listing
September 2010

Advanced pancreatic carcinoma: current treatment and future challenges.

Nat Rev Clin Oncol 2010 Mar 26;7(3):163-72. Epub 2010 Jan 26.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, ON M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2009.236
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2009.236DOI Listing
March 2010

Choice of starting dose for molecularly targeted agents evaluated in first-in-human phase I cancer clinical trials.

J Clin Oncol 2010 Mar 1;28(8):1401-7. Epub 2010 Feb 1.

Division of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.9606DOI Listing
March 2010

Cytomegalovirus infection of endocrine system in a patient with diffuse large B-cell lymphoma. Report of a case.

Tumori 2009 Jan-Feb;95(1):119-22

Department of Oncolog, Ospedale di Circolo and University of Insubria, Varese, Italy.

View Article

Download full-text PDF

Source
May 2009

Marginal zone lymphomas.

Hematol Oncol Clin North Am 2008 Oct;22(5):883-901, viii

Oncology Institute of Southern Switzerland, Ospedale San Giovanni, 6500 Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2008.07.011DOI Listing
October 2008

Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab.

Eur J Haematol 2006 Dec 17;77(6):527-9. Epub 2006 Oct 17.

Department of Oncology, Institute of Oncology of Southern Switzerland, Bellinzona, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2006.00758.xDOI Listing
December 2006